Inactive Instrument

Celator Pharmaceuticals Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2016	Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal	RE
2016	Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ	RE

Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal	16-05-31	RE
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ	16-05-31	RE
Steve Cohen’s Point72 says it has perfect U.S. compliance	16-03-17	RE

Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	16-06-13	BU
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc	16-06-02	BU
Celator Pharmaceuticals : CEO Scott Jackson and President Lawrence Mayer Interviewed by The Life Sciences Report	15-04-22	MW
Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock	14-10-28	GL
Celator(R) Pharmaceuticals to be Added to Russell MicroCap Index	14-06-27	GL

Managers	Title	Age	Since
Arthur C. Louie CTO	Chief Tech/Sci/R&D Officer	-	-

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+4.09%	43.84B
LONZA GROUP AG	+46.51%	41.25B
MODERNA, INC.	+9.45%	41.68B
CELLTRION, INC.	-10.92%	27.04B
ICON PUBLIC LIMITED COMPANY	+9.32%	25.53B
ALNYLAM PHARMACEUTICALS, INC.	-24.87%	18.18B
MEDPACE HOLDINGS, INC.	+29.70%	12.29B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	12.29B
UNITED THERAPEUTICS CORPORATION	+7.78%	11.15B